Tammy Marcotte

Founder, Player/Coach, Sales Leader, Multiple PClub Winner, Entrepreneur

Role: Senior Molecular Oncology Specialist at Agendia
Location: Orlando, FL, US
LinkedIn followers: 500 followers

About Tammy Marcotte

Tammy Marcotte is a high-energy, results-driven medical sales leader with over 25 years experience in Women\'s Health. Extensive background in device sales and top performer in areas of diagnostics, medical devices both disposable and capital equipment. Analytical and persuasive leader, with strong interpersonal and communication skills. Stable, conscientious, highly organized professional with focus on results though people.

Experience

Senior Molecular Oncology Specialist
Agendia
Nov 2023 — Present · Orlando, FL, US
The power of genomic testing is real. Empowering physicians and the women they serve with more information is my mission. No other test in breast cancer space provides molecular subtyping information. This will help guide women with treatment decisions. Thrilled to be back sharing these data as its the data that just keeps on giving!

Skills

Oncology
Cancer
Medical Sales
Interventional Radiology
Molecular Diagnostics
Operating Room
Capital Equipment
Medical Devices
Disposables
Sales Operations
Product Launch
Surgeons
Radiation Oncology
Mammography
Surgical Device Sales
Medical Imaging
Capital Equipment Sales
Medical Diagnostics
Breast Cancer
Radiation Therapy
Radiology
Surgery
Breast
General Surgery
Ultrasound

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@agendia.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Agendia

Biotechnology · 224 employees · Founded 2003 · Irvine, California, United States

Agendia, a precision oncology company, helps physicians and patients make personalized treatment decisions in early-stage breast cancer. MammaPrint® (MP), 70-gene breast cancer recurrence assay, is the only FDA-cleared (microarray) risk of recurrence test and is CE marked (IVDR-certified). BluePrint®(BP), 80-gene molecular subtyping assay, evaluates the underlying biology of a tumor to determine growth drivers. MP+BP are commercially available genomic tests, supported by clinical, guideline, peer-reviewed, and real-world evidence. They can be ordered on core biopsies or surgical specimens.* *FDA Intended Use: the test is performed for breast cancer patients with Stage I or Stage II disease with tumor size ≤5.0cm and lymph node negative. The MP FFPE result is indicated for use by physicians as a prognostic marker only, along with other clinicopathological factors. Coverage criteria for majority of US health plans include early-stage breast cancer, tumor size less than or equal to 5.0cm (≤5.0cm), up to 3 positive lymph nodes, independent of receptor status, as validated in the 6,693 patient MINDACT trial. IVDR-CE mark Intended Use: you are a female breast cancer patient with Stage I or Stage II disease who is lymph node negative or lymph node positive with up to 3 positive nodes and for patients with stage III disease. The MP FFPE result is indicated for use by physicians and should be interpreted with other clinico-pathological factors. BP was developed and its performance characteristics determined by Agendia. It has not been cleared or approved by the US FDA, which determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational or for research. This test was performed at Agendia, Inc (05D10•••50), which is certified under CLIA as qualified to perform high-complexity clinical laboratory testing. It is CE-marked for use in Europe. Social media policy: agendia.com/legal-compliance

agendia.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Tammy Marcotte

Experience

Senior Molecular Oncology Specialist

Skills

Find verified contacts for anyone on LinkedIn